KYLE CRAVER: Open Payments
NPI 1760956387 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 26 payments from 14 companies in 2025. Trend: 2023 $183 · 2024 $123 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| ABBVIE INC. | 4 | $80 |
| Lilly USA, LLC | 3 | $70 |
| PFIZER INC. | 3 | $67 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: MOUNJARO, NURTEC ODT, UBRELVY, BREZTRI, CREXONT, Dexcom G6 Transmitter, CAPLYTA, GVOKE HYPOPEN.
Industry payments across NC — which companies pay providers there.
